文献速递脑血管病

快速阿替普酶给药改善大血管闭塞卒中患者功能结局

Rapid Alteplase Administration Improves Functional Outcomes in Patients With Stroke due to Large Vessel Occlusions.
PubMed 文献 · Stroke · 2019-01-01

结果显示,入院至给药每延迟60分钟,功能独立 odds 为0.55;入院至给药<30分钟较30-60分钟功能独立绝对风险差为19.3%。

要点

  • 入院至给药每延迟60分钟,90天功能独立 odds 为0.55(95%CI 0.37-0.81)。
  • 入院至给药每延迟15分钟,极好结局率绝对下降20.3/1000例。
  • 入院至给药<30分钟较30-60分钟功能独立绝对风险差19.3%,NNT约5。

核心结论

  • 在大血管闭塞卒中患者中,更快的静脉溶栓给药与3个月时更少残疾相关。

研究设计与样本

  • 汇总HERMES协作7项随机试验的个体患者数据,分析仅限于在内血管治疗医院直接接受阿替普酶的患者,共601例。

主要发现

  • 601例患者平均年龄66.0岁(SD 13.9),50%为女性,NIHSS中位数17。
  • 发病至治疗时间中位数125分钟(IQR 90-170),入院至治疗时间中位数38分钟(IQR 26-55)。
  • 发病至治疗每延迟60分钟,90天功能独立(mRS 0-2)odds 为0.82(95%CI 0.66-1.03)。
  • 入院至给药每延迟60分钟,90天功能独立 odds 为0.55(95%CI 0.37-0.81)。
  • 症状性颅内出血发生率3.4%,无显著时间依赖性(OR 0.74,95%CI 0.43-1.28)。

关键数值与推荐

  • 入院至给药每延迟15分钟,极好结局(90天mRS 0-1)率绝对下降20.3/1000例治疗患者。
  • 入院至给药<30分钟 versus 30-60分钟,功能独立调整绝对风险差19.3%,NNT约5。

临床怎么用

  • 对大血管闭塞接受静脉阿替普酶的患者,应优化流程缩短入院至给药时间,以改善3个月功能结局。

局限性

  • 分析仅限于在内血管治疗医院直接接受阿替普酶的患者,可能限制外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- We report the relation of onset-to-treatment time and door-to-needle time with functional outcomes and mortality among patients with ischemic stroke with imaging-proven large vessel occlusion treated with intravenous alteplase. Methods- Individual patient-level data from the HERMES (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) collaboration were pooled from 7 trials that randomized patients to mechanical thrombectomy added to best medical therapy versus best medical therapy alone. Analysis was restricted to patients who received alteplase directly at the endovascular hospital. The primary outcome was disability defined on the modified Rankin Scale at 3 months. Results- Among 601 patients, mean age was 66.0 years (SD, 13.9), 50% were women, and median National Institutes of Health Stroke Scale score was 17. Onset-to-treatment time was median 125 minutes (interquartile range, 90-170). Door-to-treatment time was median 38 minutes (interquartile range, 26-55). Each 60-minute onset-to-treatment time delay was associated with greater disability at 90 days; the odds of functional independence (modified Rankin Scale, 0-2) at 90 days was 0.82 (95% CI, 0.66-1.03). With each 60-minute delay in door-to-needle time; the odds of functional independence was 0.55 (95% CI, 0.37-0.81) at 90 days. The absolute decline in the rate of excellent outcome (modified Rankin Scale, 0-1 at 90 days) was 20.3 per 1000 patients treated per 15-minute delay in door-to-needle time. The adjusted absolute risk difference for a door-to-needle time <30 minutes versus 30 to 60 minutes was 19.3% for independent outcome (number-needed-to-treat ≈5 to gain 1 additional good outcome). Symptomatic intracranial hemorrhage occurred in 3.4% of patients, without a significant time dependency: odds ratio, 0.74 (95% CI, 0.43-1.28). Conclusions- Faster intravenous thrombolysis delivery is associated with less disability at 3 months among patients with large vessel occlusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Goyal M, Almekhlafi M, Dippel DW, et al. Rapid Alteplase Administration Improves Functional Outcomes in Patients With Stroke due to Large Vessel Occlusions. Stroke. 2019. PMID: 30760169. doi:10.1161/STROKEAHA.118.021840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。